GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaron Beijing Co Ltd (SZSE:300759) » Definitions » Market Cap

Pharmaron Beijing Co (SZSE:300759) Market Cap : ¥31,642 Mil (As of Jun. 10, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Pharmaron Beijing Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Pharmaron Beijing Co's share price for the quarter that ended in Mar. 2024 was ¥20.37. Pharmaron Beijing Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 1,787 Mil. Therefore, Pharmaron Beijing Co's market cap for the quarter that ended in Mar. 2024 was ¥36,409 Mil.

Pharmaron Beijing Co's quarterly market cap declined from Sep. 2023 (¥55,567 Mil) to Dec. 2023 (¥51,779 Mil) and declined from Dec. 2023 (¥51,779 Mil) to Mar. 2024 (¥36,409 Mil).

Pharmaron Beijing Co's annual market cap declined from Dec. 2021 (¥112,194 Mil) to Dec. 2022 (¥80,992 Mil) and declined from Dec. 2022 (¥80,992 Mil) to Dec. 2023 (¥51,779 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Pharmaron Beijing Co's Enterprise Value for Today is ¥34,686 Mil.


Pharmaron Beijing Co Market Cap Historical Data

The historical data trend for Pharmaron Beijing Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaron Beijing Co Market Cap Chart

Pharmaron Beijing Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40,942.75 95,644.13 112,193.55 80,992.47 51,779.44

Pharmaron Beijing Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58,334.43 45,600.16 55,567.30 51,779.44 36,409.13

Competitive Comparison of Pharmaron Beijing Co's Market Cap

For the Biotechnology subindustry, Pharmaron Beijing Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaron Beijing Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaron Beijing Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Pharmaron Beijing Co's Market Cap falls into.



Pharmaron Beijing Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Pharmaron Beijing Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥28.98*1786.73
=¥51,779

Pharmaron Beijing Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥20.37*1787.39
=¥36,409

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmaron Beijing Co  (SZSE:300759) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Pharmaron Beijing Co Market Cap Related Terms

Thank you for viewing the detailed overview of Pharmaron Beijing Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaron Beijing Co (SZSE:300759) Business Description

Traded in Other Exchanges
Address
No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Hong Kong, HKG
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. Its operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. The company generates maximum revenue from Laboratory services segment.
Executives
Lou Xiao Qiang Directors, executives
Zheng Bei Directors, executives

Pharmaron Beijing Co (SZSE:300759) Headlines

No Headlines